Attenuating effect of post-treatment with QiShen YiQi Pills on myocardial fibrosis in rat cardiac hypertrophy

Clinical Hemorheology and Microcirculation

Volumn 51, Issue 3, 2012, Pages 177-191

  Li, Yan Chuan ^a,b   Liu, Yu Ying ^a   Hu, Bai He ^a   Chang, Xin ^a   Fan, Jing Yu ^a   Sun, Kai ^a   Wei, Xiao Hong ^a   Pan, Chun Shui ^a   Huang, Ping ^a   Chen, Yuan Yuan ^a   Wang, Chuan She ^a   Zheng, Jun ^a   Han, Jing Yan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

cardiac fibrosis; Pressure overload; salvia miltiorrhiza; transforming growth factor beta 1

Indexed keywords

CHINESE DRUG; CHLORDANE; COLLAGEN; QISHENYIQI; QISHENYIQI PILLS; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; AORTA STENOSIS; ARTICLE; ASCENDING AORTA; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; RAT; TREATMENT DURATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARDIOMEGALY; DRUGS, CHINESE HERBAL; ECHOCARDIOGRAPHY; FIBROSIS; HEART; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84863944919     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2011-1523     Document Type: Article

References (29)

1. D. Ai, W. Pang, N. Li, M. Xu, P.D. Jones, J. Yang, Y. Zhang, N. Chiamvimonvat, J.Y. Shyy, B.D. Hammock and Y. Zhu, Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy, Proc Natl Acad Sci USA 106 (2009), 564-569.
2. P. Biagi and L. Abate, Heart failure, oxidative stress and allopurinol, Monaldi Arch Chest Dis 64 (2005), 33-37.
3. P.G. Camici, From microcirculation to cardiac event: Protection with Preterax, J Hypertens 26 (2008), S8-S10.
4. A.M. Feldman, E.O. Weinberg, P.E. Ray and B.H. Lorell, Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding, Circ Res 73 (1993), 184-192.
5. J.A. Garcia and E.K. Incerpi, Factors and mechanisms involved in left ventricular hypertrophy and the anti-hypertrophic role of nitric oxide, Arq Bras Cardiol 90 (2008), 409-416.
6. J.Y. Han, Y. Horie, J.Y. Fan, K. Sun, J. Guo, S. Miura and T. Hibi, Potential of 3,4-dihydroxy-phenyl lactic acid for ameliorating ischemia-reperfusion-induced microvascular disturbance in rat mesentery, Am J Physiol Gastrointest Liver Physiol 296 (2009), G36-G44.
7. C. Hong, Y. Wang, J. Lou, Q. Liu, H. Qu and Y. Cheng, Analysis of myocardial proteomic alteration after Qishenyiqi formula treatment in acute infarcted rat hearts, Zhongguo Zhong Yao Za Zhi 34 (2009), 1018-1021.
8. P. Knaapen, T. Germans, P.G. Camici, O.E. Rimoldi, F.J. ten Cate, J.M. ten Berg, P.A. Dijkmans, R. Boellaard, W.G. van Dockum, M.J. Gotte, J.W. Twisk, A.C. van Rossum, A.A. Lammertsma and F.C. Visser, Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy, Am J Physiol Heart Circ Physiol 294 (2008), H986-H993.
9. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel and W.P. Castelli, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study, N Engl J Med 322 (1990), 1561-1516.
10. Y.L. Lin, C.H. Wu, M.H. Luo, Y.J. Huang, C.N. Wang, M.S. Shiao and Y.T. Huang, In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells, J Ethnopharmacol 105 (2006), 215-222.
11. P. Pacher, R. Schulz, L. Liaudet and C. Szabó, Nitrosative stress and pharmacological modulation of heart failure, Trends Pharmacol Sci 26 (2005), 302-310.
12. K. Rajappan, O.E. Rimoldi, D.P. Dutka, B. Ariff, D.J. Pennell, D.J. Sheridan and P.G. Camici, Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries, Circulation 105 (2002), 470-476.
13. M.Rodriguez-Porcel, X.Y. Zhu, A.R. Chade, B. Amores-Arriaga, N.M. Caplice, E.L. Ritman, A. Lerman and L.O. Lerman, Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension, Am J Physiol Heart Circ Physiol 290 (2006), H978-H984.
14. A.A. Shiozaki, T. Senra, E. Arteaga, C.G. Pita, M.M. Filho, L.F. Avila, J.R. Parga Filho, C. Mady and C.E. Rochitte, Myocardial fibrosis in patients with hypertrophic cardiomyopathy and high risk for sudden death, Arq Bras Cardiol 2010, in press.
15. D. Sorescu and K.K. Griendling, Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure, Congest Heart Fail 8 (2002), 132-140.
16. J. Tian, F. Fu, Y. Gao, Y. Zhang, Q. Meng, C. Li and F. Liu, Protections of SMND-309, a novel derivate of salvianolic acid B, on brain mitochondria contribute to injury amelioration in cerebral ischemia rats, Phytomedicine16 (2009), 726-733.
17. M. Trojanowska, E.C. LeRoy, B. Eckes and T. Krieg, Pathogenesis of fibrosis: Type 1 collagen and the skin, J Mol Med 76 (1998), 266-274.
18. J. Uitto and D. Kouba, Cytokine modulation of extracellular matrix gene expression: Relevance to fibrotic skin diseases, J Dermatol Sci 24 (2000), S60-S69.
19. C. Waller, K.H. Hiller, E. Kahler, K. Hu, M. Nahrendorf, S. Voll, A. Haase, G. Ertl and W.R. Bauer, Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart, Circulation 103 (2001), 1564-1569.
20. D.Y. Wang,Y. Li, W.H. Fan and H.C. Fan, EffectofRosewood and Integripetal rhodiola herboncollagen ratioofmyocardial infarction of rats, Chinese Tradit Patent Med 29 (2007), 1834-1835.
21. C.S. Weiss, M. Hagenmuller, M. Pichler, S. Munz, M. Ochs, S.J. Buss, R. Bekeredjian, H.A. Katus and S.E. Hardt, Activation of PPARgamma by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats, Naunyn Schmiedebergs Arch Pharmacol 381 (2010), 285-295.
22. Y. Xia, K. Lee, N. Li, D. Corbett, L. Mendoza and N.G. Frangogiannis, Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload, Histochem Cell Biol 131 (2009), 471-481.
23. J.Y. Yang, K. Sun, C.S. Wang, J. Guo, X. Xue, Y.Y. Liu, J. Zheng, J.Y. Fan, F.L. Liao and J.Y. Han, Improving effect of post-treatment with Panax notoginseng saponins on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery, Clin Hemorheol Microcirc 40 (2008), 119-131.
24. G. Yu, X. Liang, X. Xie, T. Yang, M. Sun and S. Zhao, Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan, Chin Med J (Engl) 115 (2002), 1287-1291.
25. X.Y. Yu, S.G. Lin, Z.W. Zhou, X. Chen, J. Liang, W. Duan, X.Q. Yu, J.Y. Wen, B. Chowbay, C.G. Li, F.S. Sheu, E. Chan and S.F. Zhou, Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats, Neurosci Lett 417 (2007), 261-265.
26. B.L. Zhao, W. Jiang, Y. Zhao, J.W. Hou and W.J. Xin, Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury, Biochem Mol Biol Int 38 (1996), 1171-1182.
27. N. Zhao, Y.Y. Liu, F. Wang, B.H. Hu, K. Sun, X. Chang, C.S. Pan, J.Y. Fan, X.H. Xiao, X. Li, C.S. Wang, Z.X. Guo and J.Y. Han, Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats, Am J Physiol Heart Circ Physiol 298 (2010), H1166-H1176.
28. P. Zhao, G. Su, X. Xiao, E. Hao, X. Zhu and J. Ren, Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis, Toxicol Lett 182 (2008), 29-35.
29. Y.K. Zhu, Z.P. Duan and B.E. Wang, Experimental study of Qishen Yiqi Dropping Pills on liver fibrosis in rats, Zhongguo Zhong Xi Yi Jie He Za Zhi 27 (2007), 223-226.